BD Announces Lengths Up to 300mm on Lutonix 018 Drug Coated Balloon

FRANKLIN LAKES, N.J. (Mar. 5, 2020) – BD (Becton, Dickinson, and Company) introduced longer lengths to its Lutonix^TM 018 Drug Coated Balloon (DCB) portfolio. The new 300mm sizes received approval from the U.S. Food and Drug Administration (FDA) for the treatment of femoropopliteal lesions up to 300mm and are now commercially available. With the launch of this new length, Lutonix^TM 018 DCB is the longest drug coated balloon available today in the U.S.

Lutonix^TM 018 DCB, the only DCB available on an .018” platform in the U.S., offers lengths from 40-300mm and diameters from 4-7mm on both 100 and 130cm catheter lengths. The 300mm lengths are available on 4-6mm diameters.

The 300mm Lutonix^TM 018 DCB is the latest innovation by BD Peripheral Intervention. Since Lutonix^TM 035 DCB first received FDA approval in 2014 for femoropopliteal arteries, its portfolio has expanded to include an indication and sizes for dysfunctional AV fistulae, and an .018” guidewire platform.

# # #

About BD

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com.

BD-15801